Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.

Stopped early · Phase 3

Conditions studied: Post-ischemic Stroke

In brief

This is an extension study to evaluate the long-term safety, tolerability, and efficacy of two dose strengths of dalfampridine-ER.

Key facts

Study ID

NCT02422940

Run by

Acorda Therapeutics

People needed

294

Starts

2015-04-01

Expected to finish

2017-01-01

Last updated by the study team

2019-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Acorda Site #109 — Berkeley, California, United States
• Acorda Site #170 — Carlsbad, California, United States
• Acorda Site #138 — Long Beach, California, United States
• Acorda Site #105 — Newport Beach, California, United States
• Acorda Site #142 — Pasadena, California, United States
• Acorda Site #153 — Sacramento, California, United States
• Acorda Site #151 — San Diego, California, United States
• Acorda Site #163 — San Diego, California, United States
• Acorda Site #124 — Colorado Springs, Colorado, United States
• Acorda Site #110 — Danbury, Connecticut, United States
• Acorda Site #149 — Fairfield, Connecticut, United States
• Acorda Site #130 — Stamford, Connecticut, United States
• Acorda Site #115 — Atlantis, Florida, United States
• Acorda Site #119 — Deerfield Beach, Florida, United States
• Acorda Site #147 — Gainesville, Florida, United States
• Acorda Site #128 — Hialeah, Florida, United States
• Acorda Site #184 — Jacksonville, Florida, United States
• Acorda Site #103 — Miami, Florida, United States
• Acorda Site #133 — Miami, Florida, United States
• Acorda Site #161 — Naples, Florida, United States
• Acorda Site #106 — Tampa, Florida, United States
• Acorda Site #181 — Honolulu, Hawaii, United States
• Acorda Site #171 — Chicago, Illinois, United States
• Acorda Site #148 — Avon, Indiana, United States
• Acorda Site #117 — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.